550 likes | 1.56k Views
MALARIA. causative agent = Plasmodium species 40% of world’s population lives in endemic areas 3-500 million clinical cases per year 1.5-2.7 million deaths (90% Africa) known since antiquity early medical writings from India and China Hippocrates usually credited (500 BC)
E N D
MALARIA • causative agent = Plasmodium species • 40% of world’s population lives in endemic areas • 3-500 million clinical cases per year • 1.5-2.7 million deaths (90% Africa) • known since antiquity • early medical writings from India and China • Hippocrates usually credited (500 BC) • Laveran identified parasite (1880) • Ross demonstrated mosquito transmission (1898) • Garnham described liver stage (1940’s)
Clinical Features • characterized by acute febrile attacks (malaria paroxysms) • periodic episodes of fever alternating with symptom-free periods • manifestations and severity depend on species and host status • immunity, general health, nutritional state, genetics • recrudescences or relapses can occur over months or years • can develop severe complications (especially P. falciparum)
Malaria Transmission • natural (sporozoites/Anopheles) • blood transfusions • shorter incubation period • fatality risk (P. falciparum) • no relapses possible (vivax/ovale) • syringe sharing • congenital • relatively rare although placenta is heavily infected
Prodromal Symptoms • end of incubation period • 2-3 days before 1st paroxysm • includes: malaise, fatigue, lassitude, headache, muscle pain, nausea, anorexia (i.e., flu-like symptoms) • can range from none to mild to severe • Febrile Attack (Malaria Paroxysm) • periodic febrile episodes alternating with symptom-free periods • initially fever may be irregular before developing periodicity • may be accompanied by splenomegaly, hepatomegaly (slight jaundice), anemia
cold stage • feeling of intense cold • vigorous shivering, rigor • lasts 15-60 min
hot stage • intense heat • dry burning skin • throbbing headache • lasts 2-6 hours
sweating stage • profuse sweating • declining temperature • exhausted, weak sleep • lasts 2-4 hours
Malaria Paroxysm • paroxysms associated with synchrony of merozoite release • temperature is normal and patient feels well between paroxysms • falciparum may not exhi-bit classic paroxysms • continuous fever • 24 hr periodicity tertian malaria quartan malaria
Karunaweera et al (1992) PNAS 89:3200 sweating rigor • TNF = tumor necrosis factor-a () • proinflammatory cytokine (produced in response to malarial antigens?)
Other Features of the Paroxysms • may be accompanied by spleno-megaly, hepatomegaly (slight jaundice), hemolytic anemia • P. falciparum can be lethal in non-immune (eg., children, expatriates) • paroxysms become less severe and irregular as infection progresses • semi-immune may exhibit little (1-2 days fever) or no symptoms
Anti-Parasite Immunity • immune response prevents merozoite invasion, eliminates infected erythrocytes, etc. • Anti-Disease Immunity • eg., neutralization of exo-antigens or toxic effects • Immunity • slow to develop • short lived • ‘premunition’ • non-sterilizing • lower parasitemia • less symptoms
Current Distribution of Malaria • tropical and subtropical climates • formerly widespread in temperate zones (ague) • 40% of worlds population live in endemic regions
Distribution of Malarial Parasites • P. vivax • most widespread, found in most endemic areas including some temperate zones • P. falciparum • primarily tropics and subtropics • P. malariae • similar range as P. falciparum, but less common and patchy distribution • P. ovale • occurs primarily in tropical west Africa
Malaria Epidemiology • Stable or Endemic Malaria • ~constant incidence over several years • includes seasonal transmission • immunity and disease tolerance correlates with level of endemicity (especially adults) • Unstable or Epidemic Malaria • periodic sharp increase in malaria • little immunity • high morbidity and mortality • Endemicity • Levels: • holo- • hyper- • meso- • hypo-
Roper et al (1996) AJTMH 54:325 • eastern Sudan (mesoendemic, seasonal) • rainy season June-Sept. • peak symptomatic malaria Oct.-Nov. • followed cohort of 79 individuals using thick films and PCR (P. falciparum)
Mosquito Transmission • susceptibility of anopheline species • feeding habits • density • longevity • climatic factors • temperature, humidity, rainfall, wind, etc "Everything about malaria is so moulded by local conditions that it becomes a thousand epidemiological puzzles." Hackett (1937) Anopheles
Malaria Control • Reduce Human-Mosquito Contact • impregnated bed nets • repellants, protective clothing • screens, house spraying • Reduce Vector • environmental modificaton • larvacides/insecticides • biological control • Reduce Parasite Reservoir • diagnosis and treatment • chemoprophylaxis